Marcelo Chiara Bertolami

Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019

Dalton Bertolim Précoma, Gláucia Maria Moraes de Oliveira, Antônio Felipe Leite Simão et al. · Arquivos Brasileiros de Cardiologia · 2019 · 423 citations · Full text

Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients

E Ascer, Marcelo Chiara Bertolami, Margareth L. Venturinelli et al. · Atherosclerosis · 2004 · 193 citations

Inflammation, Metabolic Syndrome, Hypercholesterolemic Patients +6

Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment

Alfredo Halpern, Márcio C. Mancini, Maria Eliane Campos Magalhães et al. · Diabetology & Metabolic Syndrome · 2010 · 169 citations · Full text

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz et al. · Queensland's institutional digital repository (The University of Queensland) · 1996 · 154 citations

Non-pharmacological Intervention, Preventive Medicine, Cardiovascular Disease +10

Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II

Christie M. Ballantyne, Marcelo Chiara Bertolami, Hugo R Hernández García et al. · American Heart Journal · 2006 · 112 citations

Health Policy, Cardiovascular Disease, B Target Levels +7